The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

BACKGROUND: Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between women, ovarian response also differs with potential negative conseq...

Descripción completa

Detalles Bibliográficos
Autores principales: van Tilborg, Theodora C, Eijkemans, Marinus JC, Laven, Joop SE, Koks, Carolien AM, de Bruin, Jan Peter, Scheffer, Gabrielle J, van Golde, Ron JT, Fleischer, Kathrin, Hoek, Annemieke, Nap, Annemiek W, Kuchenbecker, Walter KH, Manger, Petra A, Brinkhuis, Egbert A, van Heusden, Arne M, Sluijmer, Alexander V, Verhoeff, Arie, van Hooff, Marcel HA, Friederich, Jaap, Smeenk, Jesper MJ, Kwee, Janet, Verhoeve, Harold R, Lambalk, Cornelis B, Helmerhorst, Frans M, van der Veen, Fulco, Mol, Ben Willem J, Torrance, Helen L, Broekmans, Frank JM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460731/
https://www.ncbi.nlm.nih.gov/pubmed/22989359
http://dx.doi.org/10.1186/1472-6874-12-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460731/
https://www.ncbi.nlm.nih.gov/pubmed/22989359
http://dx.doi.org/10.1186/1472-6874-12-29

Ejemplares similares